Advertisement
U.S. markets closed
Advertisement

AcelRx Pharmaceuticals Inc (R5XA.MU)

Munich - Munich Delayed Price. Currency in EUR
0.7210-0.0480 (-6.24%)
At close: 08:02AM CET
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/9/2023
Current
9/30/20236/30/20233/31/202312/31/20229/30/2022
Market Cap (intraday)
11.45M8.97M11.23M6.59M17.38M31.50M
Enterprise Value
1.89M-785.57k2.04M1.69M14.44M22.81M
Trailing P/E
0.21N/A0.170.120.330.82
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
4.202.645.012.909.8611.22
Price/Book (mrq)
0.720.910.820.350.641.07
Enterprise Value/Revenue
0.88-6.718.07N/A57.3044.99
Enterprise Value/EBITDA
-0.090.55-0.523.79-1.98-3.76

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.3480
52 Week Low 30.4405
50-Day Moving Average 30.5549
200-Day Moving Average 30.7969

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 8N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq)N/A

Profitability

Profit Margin N/A
Operating Margin (ttm)N/A

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A